EVMN today
$8.02-$0.60 (-6.96%)close Nov 12, 2026Trend
DailyDowntrend (starting)
4 hourLeaning Bearish
1 hourStrong Bearish
15 minSymmetric Triangle
5 minSymmetric Triangle
Daily trend turns up above $14.44
Key levels
Resistance$11.70
Resistance$10.47
Support$4.94
Latest news & SEC filings
EarningsEvommune reports Q3 EPS of $(0.85), missing $(0.84) estimate
DealEvommune raises $30 million through private placement
DealEvommune licenses EVO570 from Hinova Pharmaceuticals on an exclusive basis
All EVMN news →About Evommune
This biotech firm creates treatments aimed at long-term inflammatory conditions. Its two main drug candidates are EVO756, taken by mouth and directed at the MRGPRX2 receptor for hives and eczema, and EVO301, an injected protein that blocks IL-18 for eczema and ulcerative colitis. The business focuses on patients in the United States.
Based on the company's 10-K filed Mar 5, 2026.
OTC · Healthcare
Functional Brands Inc. (EVMN)
What Is the Price Target for EVMN?
SEPT Low Target
$8.00
SEPT Mid Target
$24.00
SEPT High Target
$50.00
Analyst Consensus
$24.00
Is EVMN a Buy or Sell Right Now?
Thesis
- •Revenue growing 0.7% YoY with UNKNOWN trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for EVMN.
Start Free Trial →Is EVMN Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$24.00
32
Moat Score
NONE
4/9
Piotroski Score
52.0
Altman Z-Score
What Is Smart Money Doing with EVMN?
Insider Signal
SELLING
0 buys / 6 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Pena Luis C. | director officer | Buy | 1,115 | $8K | Sep 30, 2026 |
| Cohen David E | director | Sale | 5,456 | $110K | Jun 2, 2026 |
| Cohen David E | director | Sale | 600 | $13K | Jun 2, 2026 |
| Patel Jeegar Pravinkumar | officer | Buy | 13,512 | $52K | Jun 1, 2026 |
| Patel Jeegar Pravinkumar | officer | Sale | 16,687 | $379K | Jun 1, 2026 |
| Pena Luis C. | director officer | Sale | 16,787 | $382K | Jun 1, 2026 |
| Carver Kyle | officer | Buy | 15,000 | $45K | May 28, 2026 |
| Carver Kyle | officer | Sale | 18,175 | $415K | May 28, 2026 |
| Moss Gregory S. | officer | Buy | 14,223 | $24K | May 28, 2026 |
| Moss Gregory S. | officer | Sale | 14,223 | $325K | May 28, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →EVMN Growth Story
Revenue YoY
0.7%
3yr Revenue CAGR
N/A%
EPS Growth YoY
112.5%
FCF Growth YoY
-1174464.2%
Revenue Trend
UNKNOWN
Dark Pool Trades for EVMN
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for EVMN, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:04 | $8.02 | 1,051 | $$8K | SELL |
| 20:59:25 | $8.03 | 1,500 | $$12K | BUY |
| 20:57:58 | $7.99 | 1,200 | $$10K | BUY |
| 20:50:18 | $8.09 | 1,300 | $$11K | MIDPOINT |
| 20:49:56 | $8.12 | 3,352 | $$27K | BUY |
5 dark pool trades shown · $$68K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Functional Brands Inc. (EVMN) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →EVMN — frequently asked questions
What is EVMN stock price today?
Functional Brands Inc. (EVMN) is at $8.02, down 6.96% (-$0.60) at the Nov 12, 2026 close.
Why is EVMN stock moving today?
Latest EVMN news — Nov 12, 2026: Evommune reports Q3 EPS of $(0.85), missing $(0.84) estimate · Nov 5, 2026: Evommune raises $30 million through private placement
What is the EVMN price target?
The average analyst price target for EVMN is $24.00, ranging from $8 to $50, based on 6 analysts. Latest: UBS initiates on Oct 12, 2026.
What do analysts rate EVMN?
Analyst ratings for EVMN: 1 Buy, 9 Hold, 0 Sell — consensus Hold.
Did EVMN beat earnings?
EVMN last reported on Aug 6, 2026: EPS -$0.89 vs -$0.66 expected — a miss of 33.9%.
Does EVMN pay a dividend?
EVMN does not currently pay a dividend.
How much debt does EVMN have?
Functional Brands Inc. reported $0M of debt and $0M of cash (Jun 30, 2026).
What are EVMN support and resistance levels?
Support: $4.94. Resistance: $10.47, $11.70, $12.37.
What are insiders doing with EVMN?
Insider activity: SELLING, 0 buys and 6 sells in the last 90 days.
What is the latest news on EVMN?
Nov 12, 2026: Evommune reports Q3 EPS of $(0.85), missing $(0.84) estimate · Nov 5, 2026: Evommune raises $30 million through private placement · Nov 5, 2026: Evommune licenses EVO570 from Hinova Pharmaceuticals on an exclusive basis